阿片类受体通过β-阿雷斯通路影响人类角质细胞中的日间节律
Paul Bigliardi1,2, Seetanshu Junnarkar3, Chinmay Markale1,2
1Department of Dermatology, University of Minnesota, Minneapolis, MN 55455, USA.
Cells
|February 9, 2024
概括
德尔塔阿片类受体 (DOPr) 的激活通过改变昼夜节律来延迟PER2基因表达. 这种机制涉及β-arrestin-1和染色质重塑,可能会将皮肤伤口愈合与癌症发展联系起来.
科学领域:
- 皮肤病学 皮肤病学
- 时间生物学 时间生物学
- 分子生物学分子生物学
背景情况:
- 循环节律影响皮肤平衡,再生和衰老.
- PER2昼夜钟基因是一个重要的抗瘤基因.
- 德尔塔-阿片类受体 (DOPrs) 对皮肤细胞功能和癌症发展至关重要.
研究的目的:
- 调查皮肤阿片类受体 (OPr) 活性与昼夜节律性之间的关联.
- 阐明将DOPr激活与皮肤细胞中昼夜基因表达联系起来的分子机制.
主要方法:
- 进行了48小时的昼夜节律实验,每5小时取取RNA样本.
- 使用了由德克萨米他同步的N/TERT-1角质细胞.
- 采用共聚焦显微镜和ChIP测试来分析蛋白质-DNA相互作用和基因表达.
主要成果:
- 由Met-Enkephalin激活DOPr导致PER2基因表达显著延迟5.6小时.
- DOPr的激活导致DOPr-β-arrestin-1复合物的核定位.
- 对PER2促进体的β-arrestin-1结合被阶段转移,并通过DOPr激活增强,涉及基因素-4乙化.
结论:
- 通过DOPr激活,通过β-arrestin-1-介导的染色质重塑,诱导PER2表达的相位转移.
- 这种途径表明DOPr在癌症发展中的作用,反映了其在伤口愈合中的功能.
- 研究结果强调了阿片类药物信号传递和昼夜钟基因在皮肤生物学和疾病中的相互作用.
相关概念视频
Circadian Rhythms and Gene Regulation
4.1K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61
Opioid Receptors: Overview
825
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
825
Management of Insomnia
248
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
248
Analgesia and Pain Management
623
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
623
Sedatives and Hypnotics Drugs: Miscellaneous Agents
175
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
175


